Target intelligence / Profile preview

Iron-siderophore complex

Molecular classification
Other
01

Overview

The **iron-siderophore complex** is a chemical entity formed when a siderophore, a small high-affinity iron-chelating compound secreted by microorganisms, binds ferric iron (Fe(III)). This complex enables otherwise insoluble iron to be solubilized and transported into bacterial cells through specialized receptor-mediated uptake systems, mainly found in the outer membrane of Gram-negative bacteria[1][2][4][5][6]. The structural diversity of siderophores arises from distinct chelating groups (catecholates, hydroxamates, carboxylates), but all serve the function of scavenging iron from the environment. The iron-siderophore complex is recognized and imported by specific **TonB-dependent transporters** or similar proteins on the bacterial cell surface[4][6]. Inside the cell, iron is reduced and released for metabolic use, and the siderophore may be recycled or degraded[1][2]. Because iron acquisition is essential for bacterial survival and pathogenesis, the corresponding transporters/receptors (not the complex itself) are attractive antimicrobial drug targets, and "Trojan horse" antibiotics use the siderophore pathway for targeted drug delivery[6]. Essential clarification: *Iron-siderophore complex* describes a molecular assembly critical to bacterial iron uptake—highly relevant in microbiology and infection biology but should not be mistaken for a protein, receptor, or classical therapeutic target. Most drugs target the associated transport proteins, not the complex itself.

Other names
Ferric-siderophore complexFe(III)-siderophore complexferri-siderophore complex
02

Mechanism of action

Drug "hijacking" (drugs conjugated to siderophores are transported into bacteria via iron-siderophore uptake system), Inhibition of iron acquisition pathways

03

Biological functions

Iron acquisitionmicrobial survival under iron-limiting conditions
04

Disease associations

InfectionOther
05

Safety considerations

Resistance development (mutations in siderophore receptors/transporters can confer antibiotic resistance)impact on host iron homeostasis if systemically targeted
06

Interacting drugs

Sideromycin antibiotics (e.g., albomycin, cefiderocol) use the siderophore uptake system to enter bacteria; some experimental drugs target siderophore biosynthesis or transport
07

Biomarkers

Elevated siderophore levels (indirect use in infection diagnosis)specific iron-siderophore complexes can be detected in some infections

Beyond the preview

Go deeper on Iron-siderophore complex.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Iron-siderophore complex.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call